日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical development of [(18)F]TAAR1-2203 as a PET radioligand for imaging TAAR1 expression and receptor occupancy

[(18)F]TAAR1-2203 作为 PET 放射性配体用于 TAAR1 表达和受体占有率成像的临床前开发

Haider, Achi; Xiao, Zhiwei; Chen, Jiahui; Pfister, Stefanie K; Zhou, Xin; Li, Yinlong; Chaudhary, Ahmad; Zhao, Chunyu; Rong, Jian; Paehler, Axel; Mohr, Susanne; Norcross, Roger D; Honer, Michael; Mu, Linjing; Gobbi, Luca; Schibli, Roger; Hoener, Marius C; Liang, Steven H

Optimizing uPAR-targeting radiopeptides for improved tissue distribution: progress towards radionuclide therapy

优化靶向 uPAR 的放射性肽以改善组织分布:放射性核素治疗的进展

Vaccarin, Christian; Beyer, Darja; Schmid, Jerome V; Klein, Bastian; Jegathasan, Jathursa; Behera, Shreshtha; Deupi, Xavier; Schibli, Roger; Müller, Cristina

The use of mass cytometry (CyTOF) to evaluate the cellular uptake of stable radiopharmaceutical surrogates in single cells: a proof-of-concept study

利用质谱流式细胞术(CyTOF)评估单细胞对稳定放射性药物替代物的摄取:概念验证研究

Gómez-Sánchez, Miguel; Blanco-González, Elisa; Montes-Bayón, María; Behe, Martin; Schibli, Roger; Rioja-Blanco, Elisa

Patterns of complementary and alternative medicine use in pediatric patients with inflammatory bowel disease

儿童炎症性肠病患者补充和替代医学的使用模式

Guilcher, Katharina; Pittet, Valerie; Moser, André; Petit, Laetitia-Marie; Heyland, Klaas; Braegger, Christian; Nydegger, Andreas; Garzoni, Luca; Schibli, Susanne; Spalinger, Johannes; Righini-Grunder, Franziska; Sokollik, Christiane

Targeted β(-)-Particle Plus Conversion and Auger-Electron Therapy with (161)Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study

使用 (161)Tb 标记的生长抑素受体拮抗剂 DOTA-LM3 进行靶向 β(-) 粒子增强转化和俄歇电子疗法:一项 0 期研究

Fricke, Julia G; Westerbergh, Frida; McDougall, Lisa; Favaretto, Chiara; Christ, Emanuel; Nicolas, Guillaume P; Geistlich, Susanne; Schmid, David E; Borgna, Francesca; Fani, Melpomeni; Bernhardt, Peter; van der Meulen, Nicholas P; Müller, Cristina; Schibli, Roger; Wild, Damian

Alpha-synuclein interacts with regulators of ATP homeostasis in mitochondria.

α-突触核蛋白与线粒体中ATP稳态的调节因子相互作用

Serdiuk Tetiana, Fleischmann Yanick, Ghosh Dhiman, Delparente Aro, Reber Viviane, Frey Larissa, Rhyner David, Gerez Juan, Volkmar Norbert, Kralickova Lucie, Mas Guillaume, Dörig Christian, Hiller Sebastian, Schibli Roger, Mu Linjing, Picotti Paola, Riek Roland

Preclinical comparison of (radio)lanthanides using mass spectrometry and nuclear imaging techniques: biodistribution of lanthanide-based tumor-targeting agents and lanthanides in ionic form

利用质谱和核成像技术对(放射性)镧系元素进行临床前比较:镧系肿瘤靶向药物和离子态镧系元素的生物分布

Wallimann, Rahel H; Mehta, Avni; Mapanao, Ana Katrina; Köster, Ulli; Kneuer, Rainer; Schindler, Patrick; van der Meulen, Nicholas P; Schibli, Roger; Müller, Cristina

First-in-human administration of [(161)Tb]Tb-SibuDAB and comparative dosimetry with standard [(177)Lu]Lu-PSMA-I&T as part of the PROGNOSTICS phase Ia study

作为 PROGNOSTICS Ia 期研究的一部分,首次在人体内使用 [(161)Tb]Tb-SibuDAB,并与标准 [(177)Lu]Lu-PSMA-I&T 进行剂量比较。

Chirindel, Alin; Nicolas, Guillaume P; Westerbergh, Frida; McDougall, Lisa; Schmid, David E; Geistlich, Susanne; Tschan, Viviane J; Busslinger, Sarah D; Fokkema, Angelique; Aceto, Nicola; Bernhardt, Peter; van der Meulen, Nicholas P; Müller, Cristina; Wild, Damian; Schibli, Roger

Biodistribution and dosimetry of [(177)Lu]Lu-SibuDAB in patients with metastatic castration-resistant prostate cancer

[(177)Lu]Lu-SibuDAB 在转移性去势抵抗性前列腺癌患者中的生物分布和剂量学研究

Ritt, Philipp; Fernández, René; Soza-Ried, Cristian; Nicolai, Heinz; Amaral, Horacio; Krieger, Korbinian; Mapanao, Ana Katrina; Rotger, Amanda; Zhernosekov, Konstantin; Schibli, Roger; Müller, Cristina; Kramer, Vasko

Development of lisinopril radioconjugates for nuclear imaging of the angiotensin converting enzyme

赖诺普利放射性偶联物在血管紧张素转换酶核成像中的应用研究

Vaccarin, Christian; Beyer, Darja; Moiseeva, Anzhelika; Favaretto, Chiara; van der Meulen, Nicholas P; Hunkeler, Benjamin D; Rupp, Niels J; Marzaro, Giovanni; Schibli, Roger; Müller, Cristina